Shanxi Zhendong Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the eighth meeting of the sixth board of directors and the sixth meeting of the sixth board of supervisors on November 19, 2025, and the second extraordinary general meeting of shareholders in 2025 on December 18, 2025. The meetings reviewed and approved the proposals regarding the "Draft of the Fourth Employee Stock Ownership Plan of Shanxi Zhendong Pharmaceutical Co., Ltd." and its summary, as well as the "Management Measures for the Fourth Employee Stock Ownership Plan of Shanxi Zhendong Pharmaceutical Co., Ltd." and other related proposals. For specific details, please refer to the announcements disclosed by the Company on November 20, 2025, and December 18, 2025, on the Giant Tide Information Network
300158SZSE
Announcement on the Progress of the Fourth Employee Stock Ownership Plan
✨ AI Summary
Shanxi Zhendong Pharmaceutical Co., Ltd. has reported on the implementation progress of its fourth employee stock ownership plan. As of March 31, 2026, the company has purchased 28,278,018 shares, representing 2.85% of its total equity, for a total amount of 166,087,319.78 yuan. The plan is ongoing, and the company will continue to disclose relevant information as required.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.